The effects of Sp7/Osterix gene silencing in the chondroprogenitor cell line, ATDC5

Biochemical and Biophysical Research Communications

Volumn 403, Issue 2, 2010, Pages 242-246

  Omoteyama, Kazuki ^a   Takagi, Minoru ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

ATDC5; Bone; Chondrocyte; Differentiation; Osterix

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 10; TRANSCRIPTION FACTOR OSTERIX;

ANIMAL CELL; ARTICLE; ATDC5 CELL LINE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HEMATOPOIETIC STEM CELL; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CHONDROCYTES; GENE SILENCING; MICE; STEM CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 78649980063     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.023     Document Type: Article

References (22)

1. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., deCrombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
2. Yagi K., Tsuji K., Nifuji A., Shinomiya K., Nakashima K., deCrombrugghe B., Noda M. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J. Cell. Biochem. 2003, 88:1077-1083.
3. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
4. Wang X., Kua H.Y., Hu Y., Guo K., Zeng Q., Wu Q., Ng H.H., Karsenty G., deCrombrugghe B., Yeh J., Li B. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 2006, 172:115-125.
5. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., Aburatani H., Nishimura R., Yoneda T. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J. Biol. Chem. 2008, 283:29119-29125.
6. Fu H., Doll B., McNelis T., Hollinger J.O. Osteoblast differentiation in vitro and in vivo promoted by Osterix. J. Biomed. Mater. Res. A. 2007, 83:770-778.
7. Kurata H., Guillot P.V., Chan J., Fisk N.M. Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells. Tissue Eng. 2007, 13:1513-1523.
8. Yoon B.S., Ovchinnikov D.A., Yoshii I., Mishina Y., Behringer R.R., Lyons K.M. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA. 2005, 102:5062-5067.
9. Ulsamer A., Ortuno M.J., Ruiz S., Susperregui A.R., Osses N., Rosa J.L., Ventura F. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 2008, 283:3816-3826.
10. Nishio Y., Dong Y., Paris M., O'Keefe R.J., Schwarz E.M., Drissi H. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 2006, 372:62-70.
11. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 2003, 309:689-694.
12. Bendall A.J., Hu G., Levi G., Abate-Shen C. Dlx5 regulates chondrocyte differentiation at multiple stages. Int. J. Dev. Biol. 2003, 47:335-344.
13. Magee C., Nurminskaya M., Faverman L., Galera P., Linsenmayer T.F. SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes. J. Biol. Chem. 2005, 280:25331-25338.
14. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 1990, 30:109-116.
15. Shukunami C., Ishizeki K., Atsumi T., Ohta Y., Suzuki F., Hiraki Y. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 1997, 12:1174-1188.
16. Chen L., Fink T., Zhang X.Y., Ebbesen P., Zachar V. Quantitative transcriptional profiling of ATDC5 mouse progenitor cells during chondrogenesis. Differentiation 2005, 73:350-363.
17. Lou Z., Maher V.M., McCormick J.J. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein. Gene 2005, 351:51-59.
18. Weiss M.J., Ray K., Henthorn P.S., Lamb B., Kadesch T., Harris H. Structure of the human liver/bone/kidney alkaline phosphatase gene. J. Biol. Chem. 1988, 263:12002-12010.
19. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., Ryoo H.M. Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J. Biol. Chem. 2004, 279:50773-50780.
20. Piera-Velazquez S., Hawkins D.F., Whitecavage M.K., Colter D.C., Stokes D.G., Jimenez S.A. Regulation of the human SOX9 promoter by Sp1 and CREB. Exp. Cell Res. 2007, 313:1069-1079.
21. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., deCrombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002, 16:2813-2828.
22. Briggs M.R., Kadonaga J.T., Bell S.P., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 1986, 234:47-52.